RS799158 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Triglyceride levels (MTAG) | T | β: 0.095 | 7E-55 | PubMed |
| Low-density lipoprotein levels (MTAG) | T | β: 0.035 | 2E-24 | PubMed |
| Alkaline phosphatase (UKB data field 30610) | C | β: 0.039 | 1E-19 | PubMed |
| Omega-3 fatty acid levels | T | — | 7E-17 | PubMed |
| IL1RL2 protein levels | C | β: 0.089 | 1E-14 | PubMed |
| Polyunsaturated fatty acid levels | T | — | 6E-13 | PubMed |
| Polyunsaturated fatty acid levels | T | — | 6E-13 | PubMed |
| High-density lipoprotein levels (MTAG) | T | β: 0.046 | 1E-12 | PubMed |
| Omega-3 fatty acids to Omega-6 fatty acids ratio | T | — | 9E-12 | PubMed |
| Omega-3 fatty acid levels | T | — | 4E-11 | PubMed |
| Omega-6 fatty acid levels | T | — | 8E-11 | PubMed |
| Omega-3 fatty acid levels | T | — | 1E-9 | PubMed |
| Linoleic acid levels | T | — | 1E-9 | PubMed |
| Omega-6 fatty acid levels | T | — | 3E-9 | PubMed |
| Omega-3 fatty acid levels | T | — | 7E-9 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | C | β: 0.079 | 8E-9 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | T | β: 0.079 | 8E-9 | PubMed |
| Bioavailable testosterone levels | C | β: 0.028 | 2E-8 | PubMed |
| Linoleic acid to total fatty acids percentage | T | — | 2E-8 | PubMed |
| Omega-3 fatty acid levels | T | — | 5E-8 | PubMed |